All In Biotech

Drug Trial Radar · NCT04421885

Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

An Open-Label, Randomized, Single-Dose, Semi-Replicate, 4-Period, Crossover, Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

Last checked: Nov 19, 2026Latest source record: Aug 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

Jun 1, 2020

Primary completion

Jul 11, 2020

Study completion Jul 29, 2020

Sponsor

Lead sponsor
Spero TherapeuticsIndustry
Sponsor type
Industry
First posted
Jun 9, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A bioequivalence and food-effect study comparing two tablet formulations of tebipenem pivoxil hydrobromide (TBPM-PI-HBr) in healthy adult subjects.

Conditions

  • Healthy Volunteers

Interventions

  • Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - ReferenceDrug

    600 mg (2 x 300 mg tablets) clinical study drug product batch TBPM-PI-HBr.

  • Tebipenem pivoxil hydrobromide (TBPM-PI-HBr) - TestDrug

    600 mg (2 x 300 mg tablets) registration drug product batch TBPM-PI-HBr.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the curve extrapolated to infinity (AUC0-∞).Time frame: 24h (Day 2) post dose (Arms: A, B, C)
  2. Area under the concentration-time curve, from time 0 to the last observed non-zero concentration (t) (AUC0-t).Time frame: 24h (Day 2) post dose (Arms: A, B, C)
  3. Maximum plasma concentration (Cmax).Time frame: 24h (Day 2) post dose (Arms: A, B, C)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical Facility

    Tempe, Arizona

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.